Paul Batty/LinkedIn
Sep 18, 2025, 09:15
Paul Batty: The Hepatic Odyssey of AAV Gene Therapy in Hemophilia
Paul Batty, Associate Professor at University College London and Honorary Consultant in Haemostasis and Thrombosis at the Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, shared a post on X:
”Our educational review summarising the hepatic lifecycle of AAV gene therapy and how this is linked to treatment outcomes has been published in the Journal of Thrombosis and Haemostasis.”
Title: The Hepatic Odyssey of AAV: From Gene Delivery to Long-Term Outcomes
Authors: Giulia Simini, Paul Batty
Read the full article here.
Stay updated with Hemostasis Today.
-
Jan 7, 2026, 13:57Joshua Muia: Delighted to Welcome X. Long Zheng for a Versiti Seminar on TTP
-
Jan 7, 2026, 13:40Marilena Vrana Invites You to IPPC2026
-
Jan 7, 2026, 13:32Carlos Villa Joins Versiti Blood Research Institute
-
Jan 7, 2026, 13:21Bartosz Hudzik: New Evidence on “Aspirin Failure” After Ischemic Stroke
-
Jan 7, 2026, 08:50Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
-
Jan 7, 2026, 06:41Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
-
Jan 7, 2026, 05:47Michael Makris: The Wakley Prize Essay Published in Today’s Lancet is an Excellent Read
-
Jan 7, 2026, 05:36Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs
-
Jan 7, 2026, 05:15Glaivy Batsuli Reflects on ASH25